A machine learning-based gene signature of response to the novel alkylating agent LP-184 distinguishes its potential tumor indications

Peer Review reports

Original Submission
25 Nov 2020	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
11 Dec 2020	Reviewed	Reviewer Report
19 Jan 2021	Reviewed	Reviewer Report
26 Jan 2021	Author responded	Author comments - Umesh Kathad
Resubmission - Version 3
26 Jan 2021	Submitted	Manuscript version 3
6 Feb 2021	Reviewed	Reviewer Report
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
15 Feb 2021	Editorially accepted
2 Mar 2021	Article published	10.1186/s12859-021-04040-8

Back to article page